1 not yet recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow COPD Exacerbation Acute: new trials by email Literature Review of COPD Exacerbation Acute trials Research Report on COPD Exacerbation Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD R-3750 - COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbation | Phase 1 | Not yet recruiting | Rise Therapeutics LLC | 27 | 2026-09-01 | 2026-01-29 |
| Treatment of Pneumocystis in COPD (the TOPIC Study) Trimethoprim Sulfamethoxazole, Placebo - COPD Exacerbation Acute | Phase 1 / Phase 2 | Terminated | Corewell Health East | 1 | 2022-09-28 | 2023-11-29 |
Pulmonary Disease, Chronic Obstructive (2)
Chronic Disease (2) · Disease Attributes (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2)
Sugars (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Corewell Health East (1) · Rise Therapeutics LLC (1)
United States (1)